Sensitivity Analysis by Worst and Best Case Assessment: Is it Really Sensitive?
- 1 July 1999
- journal article
- other
- Published by Springer Science and Business Media LLC in Drug Information Journal
- Vol. 33 (3), 835-839
- https://doi.org/10.1177/009286159903300324
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A New Suggestion for the Classification of Missing Values in the Outcome of Clinical TrialsClinical Research and Regulatory Affairs, 1998
- EFFECT OF DROPOUTS IN A LONGITUDINAL STUDY: AN APPLICATION OF A REPEATED ORDINAL MODELStatistics in Medicine, 1996
- Biostatistical methodology in clinical trials in applications for marketing authorizations for medicinal products. CPMP working party on efficacy of medicinal products note for guidance III/3630/92‐ENStatistics in Medicine, 1995
- Statistical handling of drop‐outs in longitudinal clinical trialsStatistics in Medicine, 1992
- The Application of the Principle of Intention–to–Treat to the Analysis of Clinical TrialsDrug Information Journal, 1991
- Surrogate endpoints in clinical trials: Cardiovascular diseasesStatistics in Medicine, 1989
- The randomized clinical trial: bias in analysis.Circulation, 1981